SKNV Gears Up to Increase Production Capacity Resulting from FDA’s Recent Warnings

SKNV supports FDA’s efforts to combat adverse effects associated with the use of OTC topical numbing creams for dermatologic procedures. POMPANO BEACH, Fla., April 4, 2024 /PRNewswire/ — SKNV is increasing its manufacturing capacity to meet the growing demands of healthcare providers for…